Factors influencing serum neurofilament light chain levels in normal aging.
BMI
age
confounders
renal function
serum neurofilament light (sNfL)
Journal
Aging
ISSN: 1945-4589
Titre abrégé: Aging (Albany NY)
Pays: United States
ID NLM: 101508617
Informations de publication
Date de publication:
18 12 2021
18 12 2021
Historique:
received:
21
07
2021
accepted:
08
12
2021
pubmed:
20
12
2021
medline:
1
2
2022
entrez:
19
12
2021
Statut:
ppublish
Résumé
Serum neurofilament light (sNfL) is a promising marker for neuro-axonal damage and it is now well known that its levels also increase with higher age. However, the effect of other determinants besides age is still poorly investigated. We therefore aimed to identify factors influencing the sNfL concentration by analysing a large set of demographical, life-style and clinical variables in a normal aging cohort. sNfL was quantified by single molecule array (Simoa) assay in 327 neurologically inconspicuous individuals (median age 67.8±10.7 years, 192 female) who participated in the Austrian Stroke Prevention Family Study (ASPS-Fam). Random forest regression analysis was used to rank the association of included variables with sNfL in the entire cohort and in age-stratified subgroups. Linear regression then served to identify factors independently influencing sNfL concentration. Age (β=0.513, p<0.001) was by far the most important factor influencing sNfL, which was mainly driven by individuals ≥60 years. In age stratified sub-groups, body mass index (BMI) (β=-0.298, p<0.001) independently predicted sNfL in individuals aged 38-60 years. In individuals ≥60 years, age (β=0.394, p<0.001), renal function (β=0.376, p<0.001), blood volume (β=-0.198, p=0.008) and high density lipoprotein (HDL) (β=0.149, p=0.013) were associated with sNfL levels. Age is the most important factor influencing sNfL concentrations, getting increasingly relevant in elderly people. BMI further influences sNfL levels, especially at younger age, whereas renal function gets increasingly relevant in the elderly.
Identifiants
pubmed: 34923481
pii: 203790
doi: 10.18632/aging.203790
pmc: PMC8751593
doi:
Substances chimiques
Biomarkers
0
Neurofilament Proteins
0
neurofilament protein L
0
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
25729-25738Références
J Neurol Sci. 1994 Apr;122(2):189-203
pubmed: 8021703
Clin Chem Lab Med. 2016 Oct 1;54(10):1655-61
pubmed: 27071153
Brain Inj. 2011;25(4):370-8
pubmed: 21355671
Acta Ophthalmol. 2020 May;98(3):e393-e394
pubmed: 31602820
BMC Bioinformatics. 2007 Jan 25;8:25
pubmed: 17254353
Brain. 2020 Jul 1;143(7):1975-1998
pubmed: 32408345
Neurology. 1999 Jul 13;53(1):132-9
pubmed: 10408549
Aging (Albany NY). 2019 Sep 12;11(17):6904-6914
pubmed: 31514172
Diabetes Care. 2010 Dec;33(12):2489-95
pubmed: 20852031
Nat Commun. 2020 Feb 10;11(1):812
pubmed: 32041951
Sci Rep. 2020 Nov 23;10(1):20350
pubmed: 33230211
Neuroepidemiology. 1994;13(6):308-13
pubmed: 7800110
Transl Psychiatry. 2019 Aug 1;9(1):180
pubmed: 31371701
Ann Intern Med. 2009 May 5;150(9):604-12
pubmed: 19414839
Nat Rev Neurol. 2018 Oct;14(10):577-589
pubmed: 30171200
Stroke. 2019 Jul;50(7):1669-1675
pubmed: 31138085
J Stroke. 2018 May;20(2):228-238
pubmed: 29886723
Surgery. 1962 Feb;51(2):224-32
pubmed: 21936146
Ann Neurol. 2017 Jun;81(6):857-870
pubmed: 28512753
Ann Clin Transl Neurol. 2020 Jan;7(1):139-143
pubmed: 31893563